CraniUS LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
CraniUS LLC - overview
Established
2021
Location
Baltimore, MD, US
Primary Industry
Medical Devices & Equipment
About
Based in Maryland, US, and founded in 2021 by CTO Deborah Weidman, and CMO Chad Gordon, CraniUS LLC operates as a developer of medical devices that could help patients with chronic diseases to passage medicine directly to the brain. In January 2026, CraniUS LLC raised USD 19 million in series B funding from unspecified investors. The round was part of a larger USD 20 million series B and venture debt funding. As of September 2022, Mike Maglin is the CEO of the company.
The company provides a medical device powered by a novel wireless charging system, enabling chronic medicine delivery directly to the brain. CraniUS’s flagship product is being developed to bypass the challenges presented by the blood-brain barrier, which has rendered traditional treatments of brain disease ineffective. The company will use the January 2026 funding to support its product development and growth initiatives.
Current Investors
State of Maryland
Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare, Diagnostic Equipment, Surgical Devices
Website
www.craniustherapeutics.com
Verticals
HealthTech, Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.